Servier, which partners with local contract manufacturers, announced a €15 million investment to set up a platform called Gatinn to develop single-pill combinations for cardiometabolic and venous diseases in India
Servier, which partners with local contract manufacturers, announced a €15 million investment to set up a platform called Gatinn to develop single-pill combinations for cardiometabolic and venous diseases in India by Soban News (international And National News)
